Apple launches a study of how people use AI health tools
Apple has opened a research app, built with OpenEvidence, to learn how people use AI for health questions, according to Engadget.

The facts
- Apple has launched the Health AI Usage Study with OpenEvidence, a clinical AI platform used by health professionals, according to Engadget.
- Apple wants up to 200,000 participants. They must live in the US, be 21 or older, and have an iPhone 15 Pro or later running iOS 26 or newer.
- Participants type medical questions into the app and get plain-language answers with links to peer-reviewed clinical sources. They can also choose to share Apple HealthKit data such as activity, sleep and lab results.
- Apple says the app is not tied to Siri or Apple Intelligence, and that participant data stays confidential and will not be used to train AI models.
Case notes · Danny's take
Why it matters
Millions of people already ask chatbots about their health. Few companies have studied how those answers are actually used. Apple is collecting evidence before it builds anything, and it is anchoring the answers in peer-reviewed sources rather than a general-purpose model. That is a careful move in a space where a wrong answer can hurt someone. Most readers will also miss the sampling limit: this study covers only US users on recent iPhones, so it says little about people elsewhere.
For traders
There is no direct trading angle here. If you follow Apple, watch for any later product announcement that ties this research to Siri or Apple Intelligence. Apple says there is no such link today.
For builders
Health AI is moving towards cited, clinically grounded answers and away from confident chat. If you build in this space, plan for source links, clear privacy terms and opt-in health data. Rating the responses also shows that user feedback is treated as core data.
Not financial advice. Do your own investigation.
This story was summarised with AI from Engadget's reporting and checked against our editorial policy. Danny's take reflects his views. Disclaimer.
